Cambrex Corporation's Financials - Craft

$112 M

Revenue Q3, 2017

$1.8 B

Mkt cap, 20-Apr-2018

Gross profit (Q3, 2017)46.3 M

Gross profit margin (Q3, 2017), %41.3%

Net income (Q3, 2017)17.3 M

EBIT (Q3, 2017)25.1 M

Cash, 30-Sep-2017118.4 M

Revenue/Financials

Annual

USD	FY, 2016
Revenue	489.2 m
Cost of goods sold	286.4 m
Gross profit	202.8 m
Gross profit Margin, %	41%
R&D expense	14.3 m
General and administrative expense	60.4 m
Operating expense total	74.7 m
EBIT	128.4 m
EBIT margin, %	26%
Interest expense	717 k
Pre tax profit	127.5 m
Net Income	81.7 m

Quarterly

USD	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q3, 2017
Revenue	97.3 m	80.6 m	77.7 m	106 m	91.7 m	93.4 m	118.2 m	99.3 m	103.1 m	112 m
Cost of goods sold	64.5 m	52.9 m	48.4 m	60.7 m	57.3 m	55.8 m	70.1 m	61.8 m	58.2 m	65.7 m
Gross profit	32.9 m	27.7 m	29.3 m	45.3 m	34.4 m	37.6 m	48.1 m	37.5 m	44.9 m	46.3 m
Gross profit Margin, %	34%	34%	38%	43%	38%	40%	41%	38%	44%	41%
R&D expense	3.6 m	3.8 m	2.7 m	2.7 m	3.7 m	3.5 m	4.1 m	3.2 m	3.9 m
General and administrative expense	14.6 m	12.5 m	13.8 m	14.1 m	14 m	14 m	13.6 m	15 m	15.8 m
Operating expense total	18.2 m	16.4 m	16.4 m	16.8 m	17.7 m	17.5 m	17.7 m	18.1 m	19.6 m	21.8 m
EBIT	15.2 m	12 m	12.7 m	29.2 m	18 m	21.4 m	30.8 m	19.5 m	27.2 m	25.1 m
EBIT margin, %	16%	15%	16%	28%	20%	23%	26%	20%	26%	22%
Interest expense	543 k	570 k	476 k	474 k	517 k			366 k
Pre tax profit	10.4 m	11.4 m	12.1 m	28.9 m	17.2 m	21.4 m	30.6 m	19.2 m	26.9 m	24.8 m
Income tax expense			3.8 m			6.6 m	9.8 m	5.4 m	5.8 m	7.5 m
Net Income	20.6 m	29.4 m	8 m	27.7 m	39.4 m	14.6 m	35.1 m	44.3 m	19.9 m	17.3 m

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Cash	22.7 m	45.5 m	44 m	74.1 m
Accounts Receivable	12.9 m	10.6 m	7.3 m	6.7 m
Inventories	5.6 m	8.7 m	7.2 m	123.2 m
Current Assets	202.6 m	227.6 m	259.3 m	322.7 m
PP&E	172 m	163.6 m	186.5 m	217.1 m
Goodwill	38.7 m	43.9 m	32.1 m	40.3 m
Total Assets	458 m	487.1 m	505.5 m	611.9 m
Accounts Payable	29.1 m	43.7 m	39.3 m	42.9 m
Current Liabilities	97.3 m	98.8 m	129.8 m	95.5 m
Long-term debt	79.3 m	60 m
Total Liabilities				206.4 m
Additional Paid-in Capital	109.8 m	119.3 m	132 m	153.7 m
Retained Earnings	131.2 m	188.5 m	245.7 m	327.4 m
Total Equity	210.2 m	251.2 m	310.8 m	405.4 m
Financial Leverage	2.2 x	1.9 x	1.6 x	1.5 x

Quarterly

USD	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q3, 2017
Cash	62.6 m	60.2 m	85.6 m	52.5 m	90.7 m	99.2 m	118.4 m
Accounts Receivable	8.1 m	7.4 m	9.6 m	10.8 m	7.4 m	7.5 m	81.8 m
Inventories	127.1 m	130.9 m	131.6 m	140.1 m	143.9 m	151.5 m	5.1 m
Current Assets	253.4 m	246 m	283.8 m	279.9 m	289 m	332.8 m	378.1 m
PP&E	172.4 m	180.6 m	203.6 m	204.2 m	209.2 m	223.8 m
Goodwill	41.7 m	41.4 m	33.2 m	32.6 m	32.7 m	40.7 m	43.2 m
Total Assets	512.9 m	509.7 m	544.2 m	536.9 m	555.1 m	627.5 m	698.4 m
Accounts Payable	42.1 m	52.7 m	39.3 m	36.6 m	36.8 m	38.8 m	39.9 m
Current Liabilities	108.9 m	123.3 m	104.5 m	80.7 m	78.9 m	84.9 m	84.2 m
Long-term debt	60 m	30 m
Total Liabilities							200.5 m
Additional Paid-in Capital	123.8 m	126.9 m	133.2 m	136.8 m	141.1 m	154.9 m	162.1 m
Retained Earnings	216.1 m	227.9 m	260.3 m	280.8 m	290 m	347.2 m	389.6 m
Total Equity	272.5 m	286.4 m	335.1 m	353.1 m	366.9 m	430.5 m	497.9 m
Financial Leverage	1.9 x	1.8 x	1.6 x	1.5 x	1.5 x	1.5 x	1.4 x

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Net Income	25.9 m	57.3 m	57.2 m	81.7 m
Depreciation and Amortization	22.5 m	23.8 m	22.1 m	24.7 m
Inventories	(19 m)	(9.1 m)	(33 m)	(23.7 m)
Accounts Payable	10.1 m	12.4 m	10.3 m	1.8 m
Cash From Operating Activities	36.9 m	65 m	83.6 m	123.3 m
Cash From Investing Activities	(56.6 m)	(24.8 m)	(60.2 m)	(74 m)
Cash From Financing Activities	18.2 m	(14.5 m)	(22.7 m)	(17.3 m)
Free Cash Flow	94.2 m	88.3 m	146.1 m	73.6 m

Quarterly

USD	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q3, 2017
Net Income	20.6 m	29.4 m	8 m	27.7 m	39.4 m	14.6 m	35.1 m	44.3 m	19.9 m	17.3 m
Depreciation and Amortization	11.8 m	17.9 m	5.3 m	10.7 m	16.3 m	5.6 m	11.3 m	17.7 m	7.2 m
Accounts Receivable										81.8 m
Inventories	(16.5 m)	(22.2 m)	(29 m)	(46.5 m)	(52.5 m)	(21 m)	(35 m)	(40.1 m)	(28.2 m)	5.1 m
Accounts Payable	1.4 m	8.1 m	(2.2 m)	2.7 m	13.8 m	4 m	(12.4 m)	(11.5 m)	(10 m)	39.9 m
Cash From Operating Activities	12.5 m	41.4 m	35.4 m	40.2 m	80 m	89.8 m	64.6 m	111.8 m	36 m	72.1 m
Cash From Investing Activities	(12 m)	(20.2 m)	(12 m)	(23.5 m)	(37.5 m)	(19.8 m)	(26.5 m)	(37.7 m)	(12.2 m)	(35.4 m)
Long-term Borrowings						(30 m)	(30 m)	(30 m)
Cash From Financing Activities	(3.5 m)	(15.3 m)	1.6 m	2.2 m	(26.2 m)	(29.2 m)	(29.8 m)	(27.4 m)	725 k	3.4 m
Free Cash Flow	3.1 m	23.3 m	22.7 m	14.6 m	40.3 m	69.9 m	38.1 m	74.1 m	23.8 m	33.8 m

Report incorrect company information

View Cambrex Corporation profile

Competitors

Albany Molecular Research

Health - Public

TOMI Environmental Solutions

Health - Public

Health - Public

Precision for Medicine

Health - Private

Compare competitors